
Hemophilia B Pipeline 2024: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight | Novo Nordisk, Sanofi, ...
(MENAFN- GetNews) (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hemophilia B pipeline constitutes 15+ key companies continuously working towards developing 20+ Hemophilia B treatment therapies, analysis of Clinical …